Your browser doesn't support javascript.
loading
Everolimus in combination with vandetanib in children, adolescents, and young adults: a phase I study.
Phadnis, S; Wang, X; Daw, N C; Herzog, C E; Subbiah, I M; Zaky, W; Gouda, M A; Morani, A C; Amini, B; Harrison, D J; Piha-Paul, S A; Meric-Bernstam, F; Gorlick, R; Schwartz, C L; Subbiah, V.
Afiliação
  • Phadnis S; Division of Pediatrics, Children's of Alabama at The University of Alabama, Birmingham.
  • Wang X; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston.
  • Daw NC; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston.
  • Herzog CE; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston.
  • Subbiah IM; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston; Sarah Cannon Research Institute (SCRI), Nashville.
  • Zaky W; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston.
  • Gouda MA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston.
  • Morani AC; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston.
  • Amini B; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston.
  • Harrison DJ; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston.
  • Piha-Paul SA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston.
  • Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston.
  • Gorlick R; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston.
  • Schwartz CL; Children's Hospital of Wisconsin, Milwaukee, USA.
  • Subbiah V; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston; Sarah Cannon Research Institute (SCRI), Nashville. Electronic address: Vivek.Subbiah@scri.com.
ESMO Open ; 8(6): 101609, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37879233
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Everolimo / Neoplasias Limite: Adolescent / Adult / Child / Humans Idioma: En Revista: ESMO Open Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Everolimo / Neoplasias Limite: Adolescent / Adult / Child / Humans Idioma: En Revista: ESMO Open Ano de publicação: 2023 Tipo de documento: Article